Politico: “FDA career scientists have raised red flags about the drug’s safety and efficacy, even as the agency and the White House are under pressure to expand contraceptive options in a highly charged political environment around access to abortion, which has dramatically shrunk since the Supreme Court overturned Roe v. Wade last year.”
“FDA approval would be a major step forward for the decadeslong campaign to have the U.S. join dozens of other countries where hormonal contraceptives are available without a prescription. A decision is expected sometime this summer.”

Save to Favorites
